Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia. CAR T-cell therapy is a unique way of treating hematologic ...

Here’s news I know many readers have been anxiously awaiting: The CAR-T was a success! My 30-day and 90-day PET CTs both showed “no uptake” of the radioactive dye injected as part of the scanning ...

CAR-T therapy was originally developed for leukemias and lymphomas, and the breakthrough treatment is now also being used for autoimmune diseases. Here's a look at how the powerful CAR-T cell therapy ...

Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that ...

CAR T-cell therapy re-engineers immune cells to target and eradicate high-risk blood cancers, offering potential cures where traditional chemotherapy fails. Initially requiring inpatient care due to ...

Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...

Collaborative research explores how breakthrough engineered therapy works, why remission lasts for some patients, and how to extend its benefits This year's recipients will be exploring chimeric ...

CAR-T therapy was originally developed for leukemias and lymphomas, and the breakthrough treatment is now also being used for autoimmune diseases. Here's a look at how the powerful CAR-T cell therapy ...